P-glycoprotein and breast cancer resistance protein expression and function at the blood-brain barrier and blood-cerebrospinal fluid barrier (choroid plexus) in streptozotocin-induced diabetes in rats

被引:30
作者
Reichel, Valeska [1 ]
Burghard, Simone [1 ]
John, Isabel [1 ]
Huber, Olga [1 ]
机构
[1] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Dept Pharmaceut Technol & Biopharm, D-69120 Heidelberg, Germany
关键词
Pgp; Bcrp; Diabetes mellitus; Blood-brain barrier; Choroid plexus; ABC-TRANSPORTERS; IMPAIRED FUNCTION; KAPPA-B; PERMEABILITY; LOCALIZATION; MODULATION; MELLITUS; CORTEX;
D O I
10.1016/j.brainres.2010.11.012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The aim of the study was to investigate the influence of diabetes mellitus type 1 on expression and function of the ATP-binding cassette transport proteins P-glycoprotein (Pgp, Abcb1) and breast cancer resistance protein (Bcrp, Abcg2) at the blood-brain barrier and the blood-cerebrospinal fluid barrier formed by the choroid plexus. In brain capillary endothelial cells forming the blood-brain barrier, Pgp and Bcrp are located in the luminal membrane while apical/sub-apical localization was described for Pgp in choroid plexus epithelial cells. Alterations in expression or function may lead to damages in barrier integrity and may cause brain defects after long term diabetes. Diabetes was induced by i.p.-streptozotocin injection 14 days prior to performing experiments. RNA and protein expression were analyzed in choroid plexus and blood-brain barrier capillaries by RT-PCR and Western blot, respectively. Pgp and Bcrp expression was increased in blood-brain barrier capillaries; in choroid plexus, only Bcrp showed elevated gene expression. Protein expression was not altered. Functional analyses were carried out using confocal laser-scanning microscopy in intact isolated brain capillaries with the fluorescent Pgp substrate NBD-Cyclosporin A (NBD-CsA) and BODIPY (R) FL prazosin as substrate for Bcrp. Consistent with protein expression data, no changes in diabetic animals occurred, suggesting an unaltered function of Pgp and Bcrp. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:238 / 245
页数:8
相关论文
共 40 条
  • [21] Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1007/BF03206645
  • [22] Functional induction of P-glycoprotein in the blood-brain barrier of streptozotocin-induced diabetic rats:: evidence for the involvement of nuclear factor-κb, a nitrosative stress-sensitive transcription factor, in the regulation
    Maeng, Han-Joo
    Kim, Mi-Hwa
    Jin, Hyo-Eon
    Shin, Sang Mi
    Tsuruo, Takasi
    Kim, Sang Geon
    Kim, Dae-Duk
    Shim, Chang-Koo
    Chung, Suk-Jae
    [J]. DRUG METABOLISM AND DISPOSITION, 2007, 35 (11) : 1996 - 2005
  • [23] MAHRINGER A, 2010, MOL PHARM
  • [24] Expression of P-glycoprotein (ABCB1) and Mrp1 (ABCC1) in adult rat brain: focus on astrocytes
    Mercier, C
    Masseguin, C
    Roux, F
    Gabrion, J
    Scherrmann, JM
    [J]. BRAIN RESEARCH, 2004, 1021 (01) : 32 - 40
  • [25] Xenobiotic transport across isolated brain microvessels studied by confocal microscopy
    Miller, DS
    Nobmann, SN
    Gutmann, H
    Toeroek, M
    Drewe, J
    Fricker, G
    [J]. MOLECULAR PHARMACOLOGY, 2000, 58 (06) : 1357 - 1367
  • [26] Statins ameliorate endothelial barrier permeability changes in the cerebral tissue of streptozotocin-induced diabetic rats
    Mooradian, AD
    Haas, MJ
    Batejko, O
    Hovsepyan, M
    Feman, SS
    [J]. DIABETES, 2005, 54 (10) : 2977 - 2982
  • [27] Ivermectin excretion by isolated functionally intact brain endothelial capillaries
    Nobmann, S
    Bauer, B
    Fricker, G
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (03) : 722 - 728
  • [28] Nowicki Michael T, 2008, Drug Metab Lett, V2, P11
  • [29] Pregnane X Receptor (PXR) Regulates P-Glycoprotein at the Blood-Brain Barrier: Functional Similarities between Pig and Human PXR
    Ott, Melanie
    Fricker, Gert
    Bauer, Bjoern
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 329 (01) : 141 - 149
  • [30] Diabetes mellitus and dementia
    Pasquier, F.
    Boulogne, A.
    Leys, D.
    Fontaine, P.
    [J]. DIABETES & METABOLISM, 2006, 32 (05) : 403 - 414